1. Step 9
1.1. Review session 2
1.2. mechanism flow chart
1.3. 20 minutes
2. Step 10
2.1. Management
2.1.1. goals of manegment
2.1.1.1. eradication of the infection
2.1.1.2. inhance immunity
2.1.1.3. symptomatic reliefe
2.1.1.3.1. obtimizeing HAART therapy
2.1.1.4. improve QOL
2.1.1.5. to keep viral load below 40
2.1.1.5.1. decrese 10 folds in 4-8 weeks
2.1.2. antiretroviral
2.1.2.1. indication for HAART therapy
2.1.2.1.1. below 350 cd4
2.1.2.1.2. aportinistic infection
2.1.2.1.3. other co-morbidity
2.1.2.2. analogs and non analogs
2.1.2.2.1. can be comined with proties inhibitors
2.1.2.3. important in treating diarhea
2.1.2.4. HAART can cause diarrhea
2.1.2.5. crofemale
2.1.2.6. intry - intigrasw inhibitors
2.1.2.7. 2 NRTIs
2.1.2.7.1. recomanded
2.1.2.7.2. SE
2.1.2.8. treatment faliure
2.1.2.8.1. consider adherance of patient
2.1.2.8.2. resistants
2.1.2.8.3. role out oportinistic infection and bone marrow supression
2.1.2.9. drug - drug interaction
2.1.2.9.1. inhibit Cytocrome p450
2.1.2.10. HAART should not stop , when stoped patient devolop resistant ..
2.1.2.11. if all tratment is failing , with all regiems
2.1.2.11.1. go to palliative care
2.1.2.11.2. increasing the QOL
2.1.3. antimicrobial
2.1.3.1. nitazoxanide
2.1.3.1.1. limited efficacy
2.1.3.1.2. erradication
2.1.3.1.3. cd4 more than 200
2.1.3.1.4. antiparasitic
2.1.3.1.5. aminoglycosides
2.1.4. supportive
2.1.4.1. symptomatic reliefe
2.1.4.2. palliative therapy
2.1.4.2.1. team care
2.1.4.2.2. antimotility agents
2.1.4.2.3. social care
2.1.4.2.4. psychiatric consultation
2.2. Prevention
2.2.1. primary
2.2.1.1. crypto
2.2.1.1.1. good hiagen
2.2.1.1.2. disposal of contaminated materials
2.2.1.1.3. boil water
2.2.1.1.4. prophylactic for HIV patients
2.2.1.2. HIV
2.2.1.2.1. SEXUAL
2.2.1.2.2. BLOOD
2.2.1.2.3. mother to baby
2.2.1.3. EDUCATION
2.2.2. secondary
2.2.2.1. monetoring for cd4 counts
2.2.2.2. eraly detection for infection
2.2.2.3. blood donation screening
2.2.2.4. PROPER MANEGMENT
2.2.2.5. prophylactic medication
2.2.3. tertiary